FDA expands meningitis vaccine approval

Oct 22, 2007

The U.S. Food and Drug Administration has expanded approval for the use of Menactra, a bacterial meningitis vaccine, to children ages 2 to 10.

Menactra was first approved by the FDA in January 2005 for people ages 11 to 55. The vaccine Menomune was previously the only meningococcal vaccine available in the United States for use in children ages 2 and older, the FDA said Thursday in a release.

Both products are manufactured by Sanofi Pasteur Inc. of Swiftwater, Pa.

Meningitis, a serious inflammation of the lining that surrounds the spinal cord and brain, can cause death or permanent brain injury.

Copyright 2007 by United Press International

Explore further: Prescription drug monitoring programs offer multiple benefits

Related Stories

Designer bacteria may lead to better vaccines

Jan 15, 2013

Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera ...

HPV vaccination prevents genital warts in males

Feb 04, 2011

(PhysOrg.com) -- A new international study shows the human papillomavirus (HPV) vaccine protects against genital warts and other lesions associated with HPV in males. HPV is the most common sexually transmitted disease and ...

Recommended for you

FDA clears drug for leading form of cystic fibrosis

Jul 02, 2015

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.